Effect of Semaglutide on the Psoriatic Lesions in Patients With Type 2 Diabetes Mellitus
Status:
COMPLETED
Trial end date:
2024-06-10
Target enrollment:
Participant gender:
Summary
The use of semaglutide in patients with DMT2 and psoriasis contributes to improving the clinical picture of psoriasis and reducing the inflammatory response